Article info

Download PDFPDF
913 Molecular genetic subtypes of endometrial cancer and relationship between therapeutic efficacy of pembrolizumab in patients treated with pembrolizumab for recurrent cases in a single institute experience

Authors

Citation

Hamanishi J, Suzuki H, Ueda A, et al
913 Molecular genetic subtypes of endometrial cancer and relationship between therapeutic efficacy of pembrolizumab in patients treated with pembrolizumab for recurrent cases in a single institute experience

Publication history

  • First published March 10, 2024.
Online issue publication 
March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.